Uncategorized
Omeros reports $18.7 million net loss in first quarter
Omeros reported a net loss of $18.7 million, or $0.51 per share, in the first quarter 2015 vs. a net loss of $16.6 million, or $0.54 per share, in the first quarter 2014, according to a press release.The company had a controlled launch of Omidria (1% phenylephrine and 0.3% ketorolac injection) in the first quarter, which resulted in product revenue of $238,000. Grant revenue was $150,000 compared with $100,000 in the first quarter 2014.